Literature DB >> 19851042

Transplantation of mesenchymal stem cells to prevent radiation-induced intestinal injury in mice.

Kohsei Kudo1, Yong Liu, Kenji Takahashi, Kohetsu Tarusawa, Minoru Osanai, Dong-Liang Hu, Ikuo Kashiwakura, Hiroshi Kijima, Akio Nakane.   

Abstract

The effective treatments of radiation-induced intestinal injury are currently unavailable. Developing new treatments for radiation-induced intestinal injury is thus important. The present study investigated whether transplantation of mesenchymal stem cells (MSCs) is able to prevent radiation-induced intestinal injury. Intestines of female nude mice (ICR nu/nu) were irradiated at a single dose of 30 Gy. Transplantation of male MSCs (C57BL/6) was then immediately performed into the walls of irradiated intestine by direct injection for the irradiation + MSCs group. Mice were weighed daily and survival was recorded for 13 days after irradiation. From 13 to 27 days after irradiation, intestines of mice were obtained in order to assay histological changes by staining with hematoxylin-eosin and Masson trichrome. Mean body weight of the irradiation + MSC group was significantly higher than that of the irradiation-only group from 8 days after irradiation. In addition, survival rates were significantly higher in the irradiation + MSC group than for the irradiation-only group from 5 days after irradiation. Histological observation revealed that intestines of irradiation + MSC-transplanted mice were thick in the submucosal and muscle layers, and had almost fully recovered from radiation-induced intestinal injury at day 27. Specifically, ulcerated areas in the intestines of the irradiation + MSC-transplanted mice were smaller by 13 days after irradiation and were fewer in numbers at 27 days when compared with the irradiation-only group. Our results suggest that transplanted MSCs may play an important role in preventing radiation-induced injury and may offer a novel method to treat radiation-induced intestinal injury.

Entities:  

Mesh:

Year:  2009        PMID: 19851042     DOI: 10.1269/jrr.09091

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  21 in total

1.  Defining the optimal window for cranial transplantation of human induced pluripotent stem cell-derived cells to ameliorate radiation-induced cognitive impairment.

Authors:  Munjal M Acharya; Vahan Martirosian; Lori-Ann Christie; Lara Riparip; Jan Strnadel; Vipan K Parihar; Charles L Limoli
Journal:  Stem Cells Transl Med       Date:  2014-11-12       Impact factor: 6.940

2.  New insights for pelvic radiation disease treatment: Multipotent stromal cell is a promise mainstay treatment for the restoration of abdominopelvic severe chronic damages induced by radiotherapy.

Authors:  Alain Chapel; Sabine Francois; Luc Douay; Marc Benderitter; Jan Voswinkel
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 3.  Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review.

Authors:  Jan Voswinkel; Sabine Francois; Jean-Marc Simon; Marc Benderitter; Norbert-Claude Gorin; Mohamad Mohty; Loïc Fouillard; Alain Chapel
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

4.  Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis.

Authors:  Jixin Yang; Daniel Watkins; Chun-Liang Chen; Bharath Bhushan; Yu Zhou; Gail E Besner
Journal:  J Am Coll Surg       Date:  2012-07-21       Impact factor: 6.113

5.  Bone marrow transplantation helps restore the intestinal mucosal barrier after total body irradiation in mice.

Authors:  Sarita Garg; Wenze Wang; Biju G Prabath; Marjan Boerma; Junru Wang; Daohong Zhou; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2014-02-25       Impact factor: 2.841

6.  Exosomes secreted from bone marrow-derived mesenchymal stem cells protect the intestines from experimental necrotizing enterocolitis.

Authors:  Terrence M Rager; Jacob K Olson; Yu Zhou; Yijie Wang; Gail E Besner
Journal:  J Pediatr Surg       Date:  2016-03-02       Impact factor: 2.545

7.  Role of bone marrow-derived mesenchymal stem cells in a rat model of severe acute pancreatitis.

Authors:  Xiao-Huang Tu; Jing-Xiang Song; Xiao-Jun Xue; Xian-Wei Guo; Yun-Xia Ma; Zhi-Yao Chen; Zhong-Dong Zou; Lie Wang
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

8.  EphB2 isolates a human marrow stromal cell subpopulation with enhanced ability to contribute to the resident intestinal cellular pool.

Authors:  Evan Colletti; Deena El Shabrawy; Melisa Soland; Takashi Yamagami; Saloomeh Mokhtari; Craig Osborne; Karen Schlauch; Esmail D Zanjani; Christopher D Porada; Graça Almeida-Porada
Journal:  FASEB J       Date:  2013-02-14       Impact factor: 5.191

Review 9.  Intestinal stem cells and celiac disease.

Authors:  Anna Chiara Piscaglia
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

10.  Repeated autologous bone marrow-derived mesenchymal stem cell injections improve radiation-induced proctitis in pigs.

Authors:  Christine Linard; Elodie Busson; Valerie Holler; Carine Strup-Perrot; Jean-Victor Lacave-Lapalun; Bruno Lhomme; Marie Prat; Patrick Devauchelle; Jean-Christophe Sabourin; Jean-Marc Simon; Michel Bonneau; Jean-Jacques Lataillade; Marc Benderitter
Journal:  Stem Cells Transl Med       Date:  2013-09-25       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.